Evidence map›Paper›PMID 28153009›Full record

ArticleMalaria journal2017

Genetic diversity of Plasmodium vivax metacaspase 1 and Plasmodium vivax multi-drug resistance 1 genes of field isolates from Mauritania, Sudan and Oman.

Fatimata Sow, Guillaume Bonnot, Bilal Rabah Ahmed, Sidi Mohamed Diagana, Hachim Kebe, Mohamedou Koita, Ba Malado Samba, Said K Al-Mukhaini, Majed Al-Zadjali, Seif S Al-Abri and 8 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Cell Death ofPathogens (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 7 countries.

Fatimata SowInstitut de Chimie et Biochimie Moléculaires et Supramoléculaires ICBMS-UMR5246, CNRS-INSA-CPE, Malaria Research Unit, University Claude Bernard Lyon 1, 43 Boulevard du 11 novembre 1918, Lyon, 69622, Villeurbane, France. fatimata.sow@etu.univ-lyon1.fr.ORCID 0000-0003-0154-2349
Guillaume BonnotInstitut de Chimie et Biochimie Moléculaires et Supramoléculaires ICBMS-UMR5246, CNRS-INSA-CPE, Malaria Research Unit, University Claude Bernard Lyon 1, 43 Boulevard du 11 novembre 1918, Lyon, 69622, Villeurbane, France.
Bilal Rabah AhmedLaboratoire de Bactériologie et Parasitologie de l'Hôpital Cheikh Zayed, BP-5720, Nouakchott, Mauritania.
Sidi Mohamed DiaganaLaboratoire de Bactériologie et Parasitologie de l'Hôpital Cheikh Zayed, BP-5720, Nouakchott, Mauritania.
Hachim KebeService des Maladies Infectieuses et Tropicales, Centre Hospitalier National de Nouakchott, BP-612, Nouakchott, Mauritania.
Mohamedou KoitaLaboratoire de Parasitologie et de Mycologie Médicale Institut National de Recherches en Santé Publique (INRSP), Avenue Jemal AbdeNasser, BP-695, Nouakchott, Mauritania.
Ba Malado SambaLaboratoire Analyse de Biologie Médicale du Centre hospitalier de Rosso Mauritanie, BP-41, Rosso, Mauritania.
Said K Al-MukhainiDepartment of Infectious Diseases, The Royal Hospital, Muscat, Oman.
Majed Al-ZadjaliDepartment of Infectious Diseases, The Royal Hospital, Muscat, Oman.
Seif S Al-AbriDepartment of Infectious Diseases, The Royal Hospital, Muscat, Oman.
Osama A M AliDepartment of Infectious Diseases, The Royal Hospital, Muscat, Oman.
Abdallah M SamyEntomology Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, 11566, Egypt.
Muzamil Mahdi Abdel HamidDepartment of Parasitology and Medical Entomology, Institute of Endemic Diseases, Medical Campus, University of Khartoum, Qassr Street, P.O. BOX 102, Khartoum, Sudan.
Musab M Ali AlbsheerDepartment of Parasitology and Medical Entomology, Institute of Endemic Diseases, Medical Campus, University of Khartoum, Qassr Street, P.O. BOX 102, Khartoum, Sudan.
Bruno SimonInstitut de Chimie et Biochimie Moléculaires et Supramoléculaires ICBMS-UMR5246, CNRS-INSA-CPE, Malaria Research Unit, University Claude Bernard Lyon 1, 43 Boulevard du 11 novembre 1918, Lyon, 69622, Villeurbane, France.
Anne-Lise BienvenuInstitut de Chimie et Biochimie Moléculaires et Supramoléculaires ICBMS-UMR5246, CNRS-INSA-CPE, Malaria Research Unit, University Claude Bernard Lyon 1, 43 Boulevard du 11 novembre 1918, Lyon, 69622, Villeurbane, France.
Eskild PetersenDepartment of Infectious Diseases, The Royal Hospital, Muscat, Oman.
Stéphane PicotInstitut de Chimie et Biochimie Moléculaires et Supramoléculaires ICBMS-UMR5246, CNRS-INSA-CPE, Malaria Research Unit, University Claude Bernard Lyon 1, 43 Boulevard du 11 novembre 1918, Lyon, 69622, Villeurbane, France.
Université Claude Bernard Lyon 1 · FRMinistry of Health · OMUniversité de Nouakchott · MRUniversity of Khartoum · SDAarhus University · DKAin Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasmodium vivax is the second most important human malaria parasite, widely spread across the world. This parasite is associated with important issues in the process toward malaria elimination, including potential for relapse and increased resistance to chloroquine. Plasmodium vivax multi-drug resistant (pvmdr1) is suspected to be a marker of resistance although definitive evidence is lacking. Progress has been made in knowledge of biological factors affecting parasite growth, including mechanisms of regulated cell death and the suspected role of metacaspase. Plasmodium vivax metacaspase1 (PvMCA1-cd) has been described with a catalytic domain composed of histidine (H372) and cysteine (C428) residues. The aim of this study was to test for a link between the conserved histidine and cysteine residues in PvMCA1-cd, and the polymorphism of the P. vivax multi-drug resistant gene (pvmdr1).

resultsThirty P. vivax isolates were collected from Mauritania, Sudan, and Oman. Among the 28 P. vivax isolates successfully sequenced, only 4 samples showed the conserved His (372)-Cys (428) residues in PvMCA1-cd. Single nucleotide polymorphisms observed were H372T (46.4%), H372D (39.3%), and C428R (85.7%). A new polymorphic catalytic domain was observed at His (282)-Cys (305) residues. Sequences alignment analysis of pvmdr1 showed SNP in the three codons 958, 976 and 1076. A single SNP was identified at the codon M958Y (60%), 2 SNPs were found at the position 976: Y976F (13%) and Y976V (57%), and 3 SNPs were identified at the position 1076: F1076L (40%), F1076T (53%) and F1076I (3%). Only one isolate was wildtype in all three codons (MYF), 27% were single MYL mutants, and 10% were double MFL mutants. Three new haplotypes were also identified: the triple mutant YVT was most prevalent (53.3%) distributed in the three countries, while triple YFL and YVI mutants (3%), were only found in samples from Sudan and Mauritania.

conclusionsTriple or quadruple mutants for metacaspase genes and double or triple mutants for Pvmdr1 were observed in 24/28 and 19/28 samples. There was no difference in the frequency of mutations between PvMCA1-cd and Pvmdr1 (P > 0.2). Histidine and cysteine residues in PvMCA1-cd are highly polymorphic and linkage disequilibrium with SNPs of Pvmdr1 gene may be expected from these three areas with different patterns of P. vivax transmission.

Indexed as

Polymorphism, GeneticATP-Binding Cassette, Sub-Family C ProteinsMauritaniaOmanPlasmodium vivaxPolymorphism, Single NucleotideProtozoan ProteinsSudanATP-Binding Cassette, Sub-Family C ProteinsMdr1 protein, Plasmodium vivaxProtozoan ProteinsApoptoseDrug resistanceMauritaniaMetacaspasesOmanPlasmodium vivaxPvMCA1-cdpvmdr1 geneSNPSudan

Identifiers

PMID28153009
PMCPMC5288979
OpenAlexW2585259477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.